Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2602)	9/23/2009 3:09:48 PM
From: Jibacoa	Read Replies (1) of 3722

OPXAW was up to $2 and it is still up 55.74% as it trades at the $1.90 level at present.<g> It said that it received $500,000 as a milestone payment from NVS under a stem cell technology transfer agreement. It also received about $850,000 from the exercise of outstanding warrants at a strike price of $1.78. Novartis agreed last month to acquire its pre-clinical stage stem cell technology, and received $3M upfront payment,with another $1M to be paid as a technology transfer fee over a 6 months period..<g> (The $500,000 is part of this $1M technology transfer fee.) OPXA traded at $2 earlier. Volume is over 430Ks. I don;t know its ADV.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next